Manuel Bronstein
Known title: Chief Product OfficerCIK: 0001847776
Manuel Bronstein's purchase track record
How the stock did after each of Manuel Bronstein's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
12
of 12 since October 1, 2021
Stock higher 6 months later
33%
3 months: 50%
Median 6-month return
-15.6%
3 months: -0.8%
Beat the S&P 500
25%
median -12.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/4/2023 | RBLX | $40 | -3.8% | -16.4% | +15.6% |
| 10/19/2023 | RBLX | $93 | +22.8% | +12.3% | +17.1% |
| 8/18/2023 | RBLX | $28 | +37.8% | +56.0% | +14.5% |
| 6/1/2023 | RBLX | $339 | -32.9% | -6.7% | +8.2% |
| 3/29/2023 | RBLX | $43 | -7.0% | -36.3% | +6.1% |
| 12/22/2022 | RBLX | $53 | +59.2% | +48.1% | +14.6% |
| 6/23/2022 | RBLX | $34 | +2.3% | -23.4% | +0.7% |
| 5/9/2022 | RBLX | $103 | +98.7% | +61.8% | -4.6% |
| 4/5/2022 | RBLX | $49 | -18.4% | -21.1% | -16.2% |
| 2/22/2022 | RBLX | $187 | -43.9% | -14.8% | -4.1% |
| 1/19/2022 | RBLX | $75 | -51.7% | -46.5% | -12.6% |
| 10/1/2021 | RBLX | $222 | +36.5% | -39.1% | +4.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Roblox Engagement Rebounds as Analysts Raise Price Targets. Roblox reported a slight rebound in user engagement, offering a positive note amid broader annual declines. Several major banks, including JP Morgan, UBS, and DA Davidson, recently raised their price targets for the stock while maintaining neutral ratings. This analyst activity aligns with the company's current trading position within its 52-week range.
Transaction History
| NYT | ▲ Buy | Grant | 62 | $0 | 7/23/2026 | View on chart |
| NYT | ▲ Buy | Grant | 2,277 | $0 | 4/22/2026 | View on chart |
| NYT | ▲ Buy | Grant | 49 | $0 | 4/16/2026 | View on chart |
| NYT | ▲ Buy | Grant | 44 | $0 | 1/16/2026 | View on chart |
| NYT | ▲ Buy | Grant | 54 | $0 | 10/23/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 700 | $81K | 8/20/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 4,387 | $512K | 8/20/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 8,280 | $973K | 8/20/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 9,053 | $1.2M | 8/20/2025 | View on chart |
| NYT | ▲ Buy | Grant | 59 | $0 | 7/24/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 2,844 | $284K | 6/16/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 26,798 | $2.4M | 6/3/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 24,335 | $2.2M | 6/2/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 12,343 | $1.0M | 5/22/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 10,170 | $839K | 5/22/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 37,392 | $3.0M | 5/20/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 2,930 | $238K | 5/20/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 68,722 | $5.5M | 5/15/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 68,041 | $4.9M | 5/5/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 681 | $49K | 5/5/2025 | View on chart |
| NYT | ▲ Buy | Grant | 3,589 | $0 | 4/30/2025 | View on chart |
| NYT | ▲ Buy | Grant | 50 | $0 | 4/17/2025 | View on chart |
| RBLX | ▲ Buy | Grant | 120,969 | $0 | 3/7/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 3,100 | $188K | 2/24/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 11,621 | $712K | 2/24/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 45,219 | $2.8M | 2/20/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 300 | $19K | 2/20/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 26,149 | $1.7M | 2/11/2025 | View on chart |
| RBLX | ▲ Buy | Option Exercise | 112,046 | $0 | 2/10/2025 | View on chart |
| NYT | ▲ Buy | Grant | 33 | $0 | 1/23/2025 | View on chart |
| RBLX | ▼ Sell | Open Market | 44,888 | $2.7M | 12/11/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 6,295 | $309K | 11/22/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 4,197 | $210K | 11/22/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 7,691 | $398K | 11/20/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 37,922 | $1.9M | 11/20/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 25,148 | $1.3M | 11/4/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 12,698 | $669K | 11/4/2024 | View on chart |
| NYT | ▲ Buy | Grant | 31 | $0 | 10/24/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 15,380 | $692K | 9/11/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 40,739 | $1.8M | 9/9/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 45,817 | $1.8M | 8/20/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 71 | $3K | 8/20/2024 | View on chart |
| NYT | ▲ Buy | Grant | 31 | $0 | 7/25/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 46,494 | $1.5M | 5/21/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 3 | $92 | 5/9/2024 | View on chart |
| NYT | ▲ Buy | Grant | 4,048 | $0 | 4/24/2024 | View on chart |
| NYT | ▲ Buy | Grant | 31 | $0 | 4/18/2024 | View on chart |
| RBLX | ▲ Buy | Grant | 163,080 | $0 | 3/1/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 35,062 | $1.4M | 2/21/2024 | View on chart |
| NYT | ▲ Buy | Grant | 22 | $0 | 1/18/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 1 | $38 | 1/17/2024 | View on chart |
| RBLX | ▼ Sell | Open Market | 5,829 | $262K | 12/15/2023 | View on chart |
| RBLX | ▲ Buy | Open Market | 1 | $40 | 12/4/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 389 | $15K | 11/21/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 38,478 | $1.4M | 11/21/2023 | View on chart |
| NYT | ▲ Buy | Grant | 26 | $0 | 10/26/2023 | View on chart |
| RBLX | ▲ Buy | Open Market | 3 | $93 | 10/19/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 1 | $27 | 9/18/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 37,961 | $1.0M | 8/21/2023 | View on chart |
| RBLX | ▲ Buy | Open Market | 1 | $28 | 8/18/2023 | View on chart |
| NYT | ▲ Buy | Grant | 26 | $0 | 7/27/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 14,521 | $653K | 7/11/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 8 | $328 | 7/3/2023 | View on chart |
| RBLX | ▲ Buy | Open Market | 8 | $339 | 6/1/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 35,682 | $1.4M | 5/22/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,878 | $76K | 5/22/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 1 | $36 | 5/1/2023 | View on chart |
| NYT | ▲ Buy | Grant | 4,472 | $0 | 4/26/2023 | View on chart |
| NYT | ▲ Buy | Grant | 14 | $0 | 4/20/2023 | View on chart |
| RBLX | ▲ Buy | Grant | 160,324 | $0 | 4/13/2023 | View on chart |
| RBLX | ▲ Buy | Open Market | 1 | $43 | 3/29/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 5,335 | $240K | 3/16/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 28,089 | $1.1M | 2/21/2023 | View on chart |
| RBLX | ▼ Sell | Open Market | 633 | $24K | 2/21/2023 | View on chart |
| NYT | ▲ Buy | Grant | 14 | $0 | 1/19/2023 | View on chart |
| RBLX | ▲ Buy | Open Market | 2 | $53 | 12/22/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 25,483 | $765K | 11/21/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 6,707 | $205K | 11/21/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 1 | $30 | 11/21/2022 | View on chart |
| NYT | ▲ Buy | Grant | 15 | $0 | 10/21/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 2,612 | $118K | 9/9/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 30,819 | $1.3M | 8/22/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 2,452 | $123K | 8/12/2022 | View on chart |
| NYT | ▲ Buy | Grant | 15 | $0 | 7/21/2022 | View on chart |
| RBLX | ▲ Buy | Open Market | 1 | $34 | 6/23/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 31,995 | $970K | 5/23/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 700 | $22K | 5/23/2022 | View on chart |
| RBLX | ▲ Buy | Open Market | 4 | $103 | 5/9/2022 | View on chart |
| NYT | ▲ Buy | Grant | 3,836 | $0 | 4/27/2022 | View on chart |
| NYT | ▲ Buy | Grant | 3 | $0 | 4/21/2022 | View on chart |
| RBLX | ▲ Buy | Grant | 120,103 | $0 | 4/8/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 1 | $43 | 4/7/2022 | View on chart |
| RBLX | ▲ Buy | Open Market | 1 | $49 | 4/5/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 4 | $176 | 3/4/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 6,983 | $327K | 2/23/2022 | View on chart |
| RBLX | ▲ Buy | Open Market | 4 | $187 | 2/22/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 5,145 | $247K | 2/22/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 14,042 | $650K | 2/22/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 6,006 | $283K | 2/22/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 400 | $21K | 2/18/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 3,346 | $166K | 2/18/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 500 | $25K | 2/18/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 400 | $21K | 2/18/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,047 | $51K | 2/18/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 1 | $71 | 1/21/2022 | View on chart |
| NYT | ▲ Buy | Grant | 2 | $0 | 1/20/2022 | View on chart |
| RBLX | ▲ Buy | Open Market | 1 | $75 | 1/19/2022 | View on chart |
| RBLX | ▼ Sell | Open Market | 10,585 | $1.3M | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 5,066 | $624K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 2,711 | $336K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 679 | $85K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,101 | $142K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 267 | $35K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 217 | $29K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 380 | $51K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 151 | $20K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 271 | $37K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,244 | $150K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 395 | $47K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,876 | $227K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 907 | $115K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,310 | $167K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,917 | $246K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 696 | $91K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 54 | $7K | 11/22/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 527 | $62K | 11/22/2021 | View on chart |
| NYT | ▲ Buy | Grant | 1,602 | $0 | 11/5/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 3 | $216 | 10/8/2021 | View on chart |
| RBLX | ▲ Buy | Open Market | 3 | $222 | 10/1/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 1,790 | $161K | 8/25/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 22,284 | $2.0M | 8/24/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 986 | $88K | 8/24/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 11,575 | $944K | 8/23/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 4,808 | $403K | 8/23/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 13,071 | $1.1M | 8/23/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 2,532 | $215K | 8/23/2021 | View on chart |
| RBLX | ▼ Sell | Open Market | 3,048 | $250K | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
NYT faces scrutiny over valuation and moat in recent analysis
Recent commentary questions whether The New York Times offers sufficient value compared to other legacy media stocks, noting concerns about its competitive advantage. This skepticism aligns with the stock trading near its 52-week low and below the average analyst target price. The discussion highlights the importance of assessing long-term earnings power in the current market environment.
NYT faces scrutiny over valuation and moat in recent analysis. Recent commentary questions whether The New York Times offers sufficient value compared to other legacy media stocks, noting concerns about its competitive advantage. This skepticism aligns with the stock trading near its 52-week low and below the average analyst target price. The discussion highlights the importance of assessing long-term earnings power in the current market environment.